Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebo‐controlled, double‐blind trial
- 28 June 2005
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (7) , 2015-2025
- https://doi.org/10.1002/art.21122
Abstract
Objective To confirm preclinical data suggesting that doxycycline can slow the progression of osteoarthritis (OA). The primary outcome measure was joint space narrowing (JSN) in the medial tibiofemoral compartment. Methods In this placebo‐controlled trial, obese women (n = 431) ages 45–64 years with unilateral radiographic knee OA were randomly assigned to receive 30 months of treatment with 100 mg doxycycline or placebo twice a day. Tibiofemoral JSN was measured manually in fluoroscopically standardized radiographic examinations performed at baseline, 16 months, and 30 months. Severity of joint pain was recorded at 6‐month intervals. Results Seventy‐one percent of all randomized subjects completed the trial. Radiographs were obtained from 85% of all randomized subjects at 30 months. Adherence to the dosing regimen was 91.8% among subjects who completed the study per protocol. After 16 months of treatment, the mean ± SD loss of joint space width in the index knee in the doxycycline group was 40% less than that in the placebo group (0.15 ± 0.42 mm versus 0.24 ± 0.54 mm); after 30 months, it was 33% less (0.30 ± 0.60 mm versus 0.45 ± 0.70 mm). Doxycycline did not reduce the mean severity of joint pain, although pain scores in both treatment groups were low at baseline and remained low throughout the trial, suggesting the presence of a floor effect. However, the frequency of followup visits at which the subject reported a ≥20% increase in pain in the index knee, relative to the previous visit, was reduced among those receiving doxycycline. In contrast, doxycycline did not have an effect on either JSN or pain in the contralateral knee. In both treatment groups, subjects who reported a ≥20% increase in knee pain at the majority of their followup visits had more rapid JSN than those whose pain did not increase. Conclusion Doxycycline slowed the rate of JSN in knees with established OA. Its lack of effect on JSN in the contralateral knee suggests that pathogenetic mechanisms in that joint were different from those in the index knee.Keywords
This publication has 32 references indexed in Scilit:
- Development of radiographic changes of osteoarthritis in the “Chingford knee” reflects progression of disease or non-standardised positioning of the joint rather than incident diseaseAnnals of the Rheumatic Diseases, 2003
- The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritisArthritis & Rheumatism, 2003
- Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal diseaseStatistics in Medicine, 2001
- Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?Arthritis & Rheumatism, 1996
- Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activityArthritis & Rheumatism, 1996
- Treatment of Destructive Arthritic Disorders with MMP InhibitorsAnnals of the New York Academy of Sciences, 1994
- Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: the effect of obesity.Annals of the Rheumatic Diseases, 1994
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Patellofemoral DisordersPublished by Wolters Kluwer Health ,1984
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957